title: Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis.
authors.forename: H
authors.initials: H
authors.lastname: Hagiyama
authors.forename: T
authors.initials: T
authors.lastname: Kubota
authors.forename: Y
authors.initials: Y
authors.lastname: Komano
authors.forename: M
authors.initials: M
authors.lastname: Kurosaki
authors.forename: M
authors.initials: M
authors.lastname: Watanabe
authors.forename: N
authors.initials: N
authors.lastname: Miyasaka
mesh_terms: D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D002353:Carrier State / Q000821:virology; D004279:DNA, Viral / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D014644:Genetic Variation; D006509:Hepatitis B / Q000209:etiology* / Q000473:pathology; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008727:Methotrexate / Q000009:adverse effects*; D009154:Mutation
chemical_list: D004279:DNA, Viral; D007166:Immunosuppressive Agents; D008727:Methotrexate